Connect your practice to a world of more reliable skin cancer assessments.


One subscription. No surprise fees. 
More confident skin cancer checks.

Remote Performance Monitoring

Device is monitored remotely for sensor performance. If degraded reliability is identified, alerts are automatically sent to our field support team to either remotely diagnose and resolve, or arrange for a replacement device.

Real-Time Customer Support

Get real-time customer support, supplementary literature for ongoing education, and access to the latest publications.

Algorithm Updates from our Server

Software and algorithm updates are sent to the device from DermaSensor’s server as they become available. Stay updated and you’ll always be connected to the latest in assessment technology.

Capped Price Repairs

For complete peace of mind, we offer capped price repairs for accidental damage that may occur during the life of the equipment. Our capped price repair cost is $350 per incident, so whoopsies won’t break the bank.

Database Access

Our handheld spectrometer device uses a database of thousands of known malignant and benign lesions to return a risk assessment score, designed to augment the physician’s own clinical assessment.

Cloud Storage and Access

Connect to Wi-Fi to access DermaSensor’s cloud-based server. This allows spectral data to be transferred from your device and stored in the DermaSensor system cloud, where data is automatically checked for quality and calibration accuracy.

Expert-Hosted Webinars

Get ongoing exclusive invitations to DermaSensor-hosted CME events and webinars with expert thought leaders.


Enabling Early Detection Through Non-Invasive Optical Spectroscopy

Rapid Recording

Rapid and Reliable Recording

Scan each lesion five times and receive an objective result within seconds.

Easy to Use

Easy To Learn and Use

No training seminars needed. Just 15 minutes of simple instruction on how to incorporate the device into your workflow.
Optical Spectroscopy

Groundbreaking, Non-Invasive Technology

Show your patients that their skin health is your priority.
Risk Assessment

No Up-Front Capital Expense

An affordable way to add an additional service for your patients, without a large up-front expense.

The only skin cancer detection tool designed specifically for HCPs.

Simple Design. Effortless Application.

  • Intuitive on-screen user interface guides you step-by-step throughout the evaluation
  • Scan the lesion using either the touch-screen interface or the conveniently positioned side buttons

Non-Invasive Sub-Cellular Analysis

  • Device tip is painlessly touched to the surface of a lesion, emitting hundreds of different wavelengths of light to receive spectral data from below the skin’s surface
  • Precision optics within the tip capture pathological irregularities at a cellular and subcellular level
  • The device can be used on skin lesions as small as 2.5mm


How It Works

Lesion Identification

Lesion Identification

Identify the lesion of concern on your patient, and simply pick up the device. Now you're ready to take recordings.
DermaSensor Scan

DermaSensor Scan

Gently touch the small device tip to the lesion, taking instant spectroscopic recordings at different positions of the lesion.
Photo Scattering

Photo Scattering

Light scatters from particles in the cells of the skin tissue back to DermaSensor's spectral sensor.
Algorithmic Analysis

Algorithmic Analysis

Our proprietary algorithm analyzes the reflected photons and provides an immediate "Investigate Further" or "Monitor" result.

DermaSensor May Help You To:

  • Make better and more confident decisions
  • Detect all skin cancers with 97% sensitivity1
  • Catch 13% more skin cancer as demonstrated in a study with 57 GPs2
  • Augment your typical skin assessment routine and increase your reimbursement level
  • Increase revenue by introducing a value-based skin health service with out of pocket contributions by patients
  • Improve your practice’s image by incorporating new and innovative technology
DermaSensor Confidence Circle

See how the DermaSensor platform integrates into your practice.

The DermaSensor device is not a screening tool—lesions that clearly warrant a biopsy should be biopsied per normal clinical practice. And clearly benign lesions do not require the use of the DermaSensor Device.

The device can be used an unlimited number of times per month, but we estimate the average practice might use the device between 10 and 50 times per month. Therefore, we suggest that practices charge a nominal fee for an optical scan of a lesion with our device which could rule out the need for a more invasive biopsy.

Est. Avg. Device Usage


Times per Month

DermaSensor May Help You

  • Make better and more confident decisions
  • Increase your reimbursement level by augmenting your typical skin assessment routine
  • Increase revenue by introducing a value-based skin health service with out-of-pocket contributions by patients
  • Improve your practice’s image by incorporating new and innovative technology

DermaSensor May Help Your Patients

  • Avoid unnecessary biopsies
  • Avoid additional visits to a dermatologist, along with the associated out-of-pocket expenses
  • Feel more confident about questionable lesions

Potential Use Cases

  • Elderly patient has a questionable lesion, but also has skin that would require lengthy healing time.
  • A young patient has a questionable lesion on their face, and is concerned about disfigurement.
  • Overcome challenges in communicating risk assessment and treatment urgency between the HCP and patient.
  • Extend lesion evaluation to other trained team members.

Built for the Front Lines

Enabling Healthcare Professionals

Australians usually consult a General Practitioner (GP) to conduct skin health examinations, in part due to unavailability of specialists. But early diagnosis in primary care is often hampered by limited consultation time. Still, GPs undertake more than 1 million consultations for skin cancer annually.

GPs are at the front line of skin cancer detection for most Australians. DermaSensor will help you better assess identified skin lesions and determine whether patients need additional clinical care. All trained members of the healthcare team will be able to benefit from the device's simple-to-use design. Detecting cancer at an earlier stage holds the potential to save lives, and our device provides a quicker route to identifying skin cancer risk.

Download Brochure

Technical Specifications



Unit and Base

  • Height: 234mm
  • Width: 105mm
  • Depth: 105mm

Handheld Unit

  • Height: 180mm
  • Width: 70mm
  • Depth: 37mm


  • Height: 149mm
  • Width: 108mm
  • Depth: 108mm


  • Packaged Weight: 1.9kg
  • Handheld Unit: 295gm
  • Base/Power Socket: 585gm


Dark Grey


Requires WiFi internet connection

Battery Life

Battery life will last a full day in practice*

*by keeping the device in the charging base between uses


Standard 110v-250v / 50-60Hz general power outlet (GPO)


Wireless Charging


1-Year Warranty from date of delivery to customer site

What's in the Box

  • Device (both handheld unit and base) pre-installed with software
  • Operating Manual
  • Recyclable Packaging


Product Support

Need help integrating DermaSensor into your practice? Contact a DermaSensor expert for for assistance subscribing to a DermaSensor plan, or assistance with your existing DermaSensor device.

Sales Support

For further information and sales support please contact us.

Contact Us

Technical Services

For further information on technical matters please contact us.

Contact Us


Video and content support from experts on evaluation and more.

Support Portal Login

Make DermaSensor your new assistant for skin cancer care.

99% of all skin cancer is curable if detected early. Our device has the potential to equip frontline providers to quickly and effectively check for all common types of skin cancer (melanoma, basal cell carcinoma, squamous cell carcinoma).

Add DermaSensor’s system to your practice today and get access to a world of better skin tests with the power to save lives.

Book a Demo


1Manolakos D et al. Clinical Validation of a Handheld Elastic Scattering Spectroscopy Artificial Intelligence Device, Presentation at American Academy of Dermatologists Innovation Academy, July 20-24, 2022.

2Thames T et al. Clinical Utility of a Handheld Elastic Scattering Spectroscopy Tool and Machine Learning on the Diagnosis and Management of Skin Cancer. Poster Presentation, STFM Annual Spring Conference, April 30-May 4, 2022.

80-0006.2 v2

Scroll to Top